Total Voting Rights

Summary by AI BETAClose X

AstraZeneca PLC has announced that as of February 28, 2026, its issued share capital with voting rights comprises 1,550,966,708 ordinary shares, with no shares held in treasury, resulting in a total of 1,550,966,708 voting rights. This figure serves as the denominator for shareholders to determine notification requirements under the UK Financial Conduct Authority's Disclosure and Transparency Rules regarding their interests in the company.

Disclaimer*

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings